ResearcherUniversity of MichiganActive in the last 2 years
Michelle Ann Anderson
Matched on ORCID iD 0000-0002-8416-4218; OpenAlex author ID A5002219265; NIH RePORTER profile ID 1973631. Sources: OpenAlex.
Their work
- Papers
- 13
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 57
2011: 2 papers · 2012: 2 papers, 1 grant · 2013: none · 2014: 4 papers · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 13
- Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium. Co-author DOI 10.1200/po-25-00696↗
- KRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1158/1078-0432.ccr-23-1421↗
- Multimodal Mapping of the Tumor and Peripheral Blood Immune Landscape in Human Pancreatic Cancer. Co-author DOI 10.1038/s43018-020-00121-4↗
- Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. Co-author DOI 10.1021/acs.jproteome.5b00068↗
- Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Co-author DOI 10.1371/journal.pone.0139049↗
- Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS. Co-author DOI 10.1002/elps.201300376↗
- A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Co-author DOI 10.1016/j.tranon.2014.07.005↗
- Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. Co-author DOI 10.1021/pr400967x↗
- Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method. Co-author DOI 10.1021/pr500934u↗
- Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Co-author DOI 10.1038/ajg.2012.288↗
- Plasma Shh levels reduced in pancreatic cancer patients. Co-author DOI 10.1097/mpa.0b013e31824a0eeb↗
- Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. Co-author DOI 10.1021/pr200102h↗
- PCCR: Pancreatic Cancer Collaborative Registry. Co-author DOI 10.4137/cin.s6919↗
Grants 1
Closest collaborators
The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Diane M. Simeone · 7 shared papers, 2011–2015 · strength 0.28
- Paper Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. DOI 10.1021/acs.jproteome.5b00068↗
- Paper Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-… DOI 10.1002/elps.201300376↗
- Paper Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric l… DOI 10.1021/pr500934u↗
- David M. Lubman · 5 shared papers, 2011–2015 · strength 0.21
- Paper Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. DOI 10.1021/acs.jproteome.5b00068↗
- Paper Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-… DOI 10.1002/elps.201300376↗
- Paper Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric l… DOI 10.1021/pr500934u↗
- Mack T. Ruffin · 5 shared papers, 2011–2015 · strength 0.21
- Paper Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. DOI 10.1021/acs.jproteome.5b00068↗
- Paper Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-… DOI 10.1002/elps.201300376↗
- Paper Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric l… DOI 10.1021/pr500934u↗
- Samantha B. Kemp · 2 shared papers, 2020–2024 · strength 0.20
- Nina G. Steele · 2 shared papers, 2020–2024 · strength 0.20
- Eileen S. Carpenter · 2 shared papers, 2020–2024 · strength 0.20
- Valerie Gunchick · 2 shared papers, 2020–2024 · strength 0.20
- Marina Pasca di Magliano · 2 shared papers, 2020–2024 · strength 0.20
- Katelyn L. Donahue · 2 shared papers, 2020–2024 · strength 0.20
- Timothy L. Frankel · 2 shared papers, 2020–2024 · strength 0.20
- Vaibhav Sahai · 2 shared papers, 2020–2024 · strength 0.20
- Filip Bednar · 2 shared papers, 2020–2024 · strength 0.20
- Zhijing Tan · 3 shared papers, 2014–2015 · strength 0.14
- Paper Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. DOI 10.1021/acs.jproteome.5b00068↗
- Paper Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric l… DOI 10.1021/pr500934u↗
- Paper Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. DOI 10.1021/pr400967x↗
- Song Nie · 3 shared papers, 2014–2015 · strength 0.14
- Paper Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. DOI 10.1021/acs.jproteome.5b00068↗
- Paper Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric l… DOI 10.1021/pr500934u↗
- Paper Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. DOI 10.1021/pr400967x↗
- Zeribe C. Nwosu · 1 shared paper, 2024 · strength 0.13
- Wenting Du · 1 shared paper, 2024 · strength 0.13
- Rémy Nicolle · 1 shared paper, 2024 · strength 0.13
- Jorge D. Machicado · 1 shared paper, 2024 · strength 0.13
- Padma Kadiyala · 1 shared paper, 2024 · strength 0.13
- Ahmed M. Elhossiny · 1 shared paper, 2024 · strength 0.13
- Jiaqi Shi · 1 shared paper, 2024 · strength 0.13
- Zhenxin Lin · 3 shared papers, 2011–2015 · strength 0.13
- Paper Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. DOI 10.1021/acs.jproteome.5b00068↗
- Paper Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-… DOI 10.1002/elps.201300376↗
- Paper Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. DOI 10.1021/pr200102h↗
- Randall E. Brand · 4 shared papers, 2011–2015 · strength 0.11
- Paper Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specim… DOI 10.1371/journal.pone.0139049↗
- Paper Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. DOI 10.1021/pr200102h↗
- Paper Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicent… DOI 10.1038/ajg.2012.288↗
- Jianhui Zhu · 2 shared papers, 2014–2015 · strength 0.09
- Benjamin Allen · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.